ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,947, issued on June 2, was assigned to The Regents of the University of California (Oakland, Calif.).

"Anti-ROR-2 antibodies and methods of use" was invented by Thomas J. Kipps (San Diego) and George F. Widhopf II (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are, inter alia, antibodies (e.g., humanized antibodies, monoclonal antibodies), antibody fragments (e.g., scFvs) and antibody compositions (e.g., chimeric antigen receptors, bispecific antibodies), which bind human tyrosine kinase-like orphan receptor 2 (ROR2) with high efficiency and specificity. The antibodies and antibody compositions provided herein include novel...